FDA Brief

Warning letters Biologics

FDA warning letter to

Cooper Institute

Issued Dec 15, 2021Posted Dec 14, 2021Office of Biological Products Operations – Division 2

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.